Literature DB >> 11912272

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease.

Karl F Hilgers1, Johannes F E Mann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11912272     DOI： 10.1681/ASN.V1341100

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  23 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria.

Authors:  Niels Holmark Andersen; Carl Erik Mogensen
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

2.  Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade.

Authors:  Lavjay Butani
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

3.  Urgent call for reconsideration of chronic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2012-12-06

Review 4.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 5.  Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.

Authors:  Mark A Perazella; John F Setaro
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

6.  Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Mabel Missoni; Clarisa Vezzani
Journal:  Pediatr Nephrol       Date:  2012-12-20       Impact factor: 3.714

7.  Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis.

Authors:  Steven D Crowley; Matthew P Vasievich; Phillip Ruiz; Samantha K Gould; Kelly K Parsons; A Kathy Pazmino; Carie Facemire; Benny J Chen; Hyung-Suk Kim; Trinh T Tran; David S Pisetsky; Laura Barisoni; Minolfa C Prieto-Carrasquero; Marie Jeansson; Mary H Foster; Thomas M Coffman
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 8.  Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Authors:  Karl F Hilgers; Jörg Dötsch; Wolfgang Rascher; Johannes F E Mann
Journal:  Pediatr Nephrol       Date:  2004-07-22       Impact factor: 3.714

Review 9.  Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.

Authors:  Niels H Andersen; Carl E Mogensen
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

10.  P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway.

Authors:  Oliver Vonend; Tobias Grote; Vitus Oberhauser; Ivar Von Kügelgen; Lars Christian Rump
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.